<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">avk</journal-id><journal-title-group><journal-title xml:lang="ru">Архивъ внутренней медицины</journal-title><trans-title-group xml:lang="en"><trans-title>The Russian Archives of Internal Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-6704</issn><issn pub-type="epub">2411-6564</issn><publisher><publisher-name>“SINAPS” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20514/2226-6704-2022-12-6-405-421</article-id><article-id custom-type="elpub" pub-id-type="custom">avk-1530</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group></article-categories><title-group><article-title>КАНАЛЬЦЕВЫЙ АППАРАТ ПОЧЕК — НАУЧНОЕ И ПРИКЛАДНОЕ ЗНАЧЕНИЕ</article-title><trans-title-group xml:lang="en"><trans-title>Kidney Tubules — Scientific and Applied Value</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6165-3943</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Левицкая</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Levitskaya</surname><given-names>E. S</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатерина Сергеевна Левицкая</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Ekaterina S. Levitskaya</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">es.med@mai.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батюшин</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Batiushin</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Rostov-on-Don</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Ростовский государственный медицинский университет» Министерства здравоохранения Российской Федерации, кафедра внутренних болезней № 2</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education «Rostov State Medical University» of the Ministry of Healthcare of the Russian Federation, Department of Internal Dis-eases № 2</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>29</day><month>11</month><year>2022</year></pub-date><volume>12</volume><issue>6</issue><fpage>405</fpage><lpage>421</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Левицкая Е.С., Батюшин М.М., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Левицкая Е.С., Батюшин М.М.</copyright-holder><copyright-holder xml:lang="en">Levitskaya E.s., Batiushin M.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medarhive.ru/jour/article/view/1530">https://www.medarhive.ru/jour/article/view/1530</self-uri><abstract><p> </p><p>В настоящее время существует высокий научный интерес к изучению особенностей структуры и функций канальцев почек. Актуальность темы обусловлена потенциальной возможностью выявления разнообразных маркеров нарушения функции канальцев и использования их для ранней диагностики не только тубулопатий, но и гломерулярных нарушений. В клинической практике маркеры канальцевой дисфункции используются недостаточно. В статье представлены сведения об анатомо-функциональных особенностях проксимального и дистального отделов канальцевого аппарата, изложены высокоорганизованные механизмы межмолекулярного взаимодействия, представлены основные биологически активные вещества, изменение концентрации которых является следствием повреждения канальцев. Представленная рукопись является продуктом глубокого анализа и систематизации имеющихся данных в российских и зарубежных информационно-аналитических порталах.</p></abstract><trans-abstract xml:lang="en"><p>Currently, there is a high scientific interest in studying the features of the structure and functions of the tubules of the kidneys. The relevance of the topic is due to the potential possibility of identifying various markers of tubular dysfunction and using them for early diagnosis of not only tubulopathies, but also glomerular disorders. In clinical practice, markers of tubular dysfunction are used insufficiently. The article presents information about the anatomical and functional features of the proximal and distal parts of the tubular apparatus, outlines highly organized mechanisms of intermolecular interaction, presents the main biologically active substances, the change in the concentration of which is a consequence of damage to the tubules. The presented manuscript is the product of a deep analysis and systematization of the available data in Russian and foreign information and analytical portals.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>структура и функция канальцев почек</kwd><kwd>маркеры канальцевой дисфункц</kwd></kwd-group><kwd-group xml:lang="en"><kwd>structure and function of renal tubules</kwd><kwd>markers of tubular dysfunction</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Curthoys NP, Moe OW. Proximal Tubule Function and Response to Acidosis. Clin J Am Soc Nephrol. 2014; 9(9): 1627-1638. doi: 10.2215/CJN.10391012.</mixed-citation><mixed-citation xml:lang="en">Curthoys NP, Moe OW. Proximal Tubule Function and Response to Acidosis. Clin J Am Soc Nephrol. 2014; 9(9): 1627-1638. doi: 10.2215/CJN.10391012.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Andrianova NV, Buyan MI, Zorova LD et al. Kidney Cells Regeneration: Dedifferentiation of Tubular Epithelium, Resident Stem Cells and Possible Niches for Renal Progenitors. Int J Mol Sci. 2019; 20(24): 6326. doi: 10.3390/ijms20246326.</mixed-citation><mixed-citation xml:lang="en">Andrianova NV, Buyan MI, Zorova LD et al. Kidney Cells Regeneration: Dedifferentiation of Tubular Epithelium, Resident Stem Cells and Possible Niches for Renal Progenitors. Int J Mol Sci. 2019; 20(24): 6326. doi: 10.3390/ijms20246326.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Little MH, Kairath P. Does Renal Repair Recapitulate Kidney Development? JASN. 2017; 28 (1): 34-46. doi: 10.1681/ASN.2016070748.</mixed-citation><mixed-citation xml:lang="en">Little MH, Kairath P. Does Renal Repair Recapitulate Kidney Development? JASN. 2017; 28 (1): 34-46. doi: 10.1681/ASN.2016070748.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Castrop H. The Role of Renal Interstitial Cells in Proximal Tubular Regeneration. Nephron 2019; 141: 265-272. doi: 10.1159/000496278.</mixed-citation><mixed-citation xml:lang="en">Castrop H. The Role of Renal Interstitial Cells in Proximal Tubular Regeneration. Nephron 2019; 141: 265-272. doi: 10.1159/000496278.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Yoon YM, Go G, Yun CW et al. Knockdown of CK2α reduces P-cresol-induced fibrosis in human renal proximal tubule epithelial cells via the downregulation of profilin-1. Int J Med Sci. 2020; 17(17): 2850-2860. doi:10.7150/ijms.48429.</mixed-citation><mixed-citation xml:lang="en">Yoon YM, Go G, Yun CW et al. Knockdown of CK2α reduces P-cresol-induced fibrosis in human renal proximal tubule epithelial cells via the downregulation of profilin-1. Int J Med Sci. 2020; 17(17): 2850-2860. doi:10.7150/ijms.48429.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chawla LS., Bellomo R, Bihorac A, on behalf of the Acute Disease Quality Initiative Workgroup 16. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nature Reviews Nephrology. 2017; 13: 241-257. doi:10.1038/nrneph.2017.2.</mixed-citation><mixed-citation xml:lang="en">Chawla LS., Bellomo R, Bihorac A, on behalf of the Acute Disease Quality Initiative Workgroup 16. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nature Reviews Nephrology. 2017; 13: 241-257. doi:10.1038/nrneph.2017.2.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chevalier RL. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Renal Physiol. 2016; 311(1): F145-F161. doi: 10.1152/ajprenal.00164.2016.</mixed-citation><mixed-citation xml:lang="en">Chevalier RL. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Renal Physiol. 2016; 311(1): F145-F161. doi: 10.1152/ajprenal.00164.2016.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fortrie G, de Geus HRH., Betjes MGH. The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function. Crit Care. 2019; 23: 24. doi: 10.1186/s13054-019-2314-z.</mixed-citation><mixed-citation xml:lang="en">Fortrie G, de Geus HRH., Betjes MGH. The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function. Crit Care. 2019; 23: 24. doi: 10.1186/s13054-019-2314-z.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pereira BJ, Barreto S, Gentil T et al. Risk factors for the progression of chronic kidney disease after acute kidney injury. J. Bras. Nefrol. 2017; 39: 239-245. d doi: 10.5935/0101-2800.20170041.</mixed-citation><mixed-citation xml:lang="en">Pereira BJ, Barreto S, Gentil T et al. Risk factors for the progression of chronic kidney disease after acute kidney injury. J. Bras. Nefrol. 2017; 39: 239-245. d doi: 10.5935/0101-2800.20170041.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gilbert RE. Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease. Diabetes. 2017; 66: 791-800. doi: 10.2337/db16-0796.</mixed-citation><mixed-citation xml:lang="en">Gilbert RE. Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease. Diabetes. 2017; 66: 791-800. doi: 10.2337/db16-0796.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chagnaca A, Zingermana B, Rozen-Zvia B et al. Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity. Nephron. 2019; 143: 38-42. doi: 10.1159/000499486.</mixed-citation><mixed-citation xml:lang="en">Chagnaca A, Zingermana B, Rozen-Zvia B et al. Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity. Nephron. 2019; 143: 38-42. doi: 10.1159/000499486.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Vallon, V., Thomson, S.C. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol. 2020; 16: 317-336. doi: 10.1038/s41581-020-0256-y.</mixed-citation><mixed-citation xml:lang="en">Vallon, V., Thomson, S.C. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol. 2020; 16: 317-336. doi: 10.1038/s41581-020-0256-y.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Habib SL. Kidney atrophy vs hypertrophy in diabetes: which cells are involved? Cell Cycle. 2018; 17(14): 1683-1687. doi: 10.1080/15384101.2018.1496744.</mixed-citation><mixed-citation xml:lang="en">Habib SL. Kidney atrophy vs hypertrophy in diabetes: which cells are involved? Cell Cycle. 2018; 17(14): 1683-1687. doi: 10.1080/15384101.2018.1496744.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenberg AZ, Kopp JB. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2017; 12: 502-517. doi: 10.2215/CJN.05960616.</mixed-citation><mixed-citation xml:lang="en">Rosenberg AZ, Kopp JB. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2017; 12: 502-517. doi: 10.2215/CJN.05960616.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016; 23(1): 19-28. doi: 10.1053/j.ackd.2015.08.004.</mixed-citation><mixed-citation xml:lang="en">Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016; 23(1): 19-28. doi: 10.1053/j.ackd.2015.08.004.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Amini S., Abbaspour H., Morovatdar N. et al. Risk Factors and Outcome of Acute Kidney Injury after Congenital Heart Surgery: A Prospective Observational Study. Indian J Crit Care Med. 2017; 21(12): 847-851. doi: 10.4103/ijccm.IJCCM_459_16.</mixed-citation><mixed-citation xml:lang="en">Amini S., Abbaspour H., Morovatdar N. et al. Risk Factors and Outcome of Acute Kidney Injury after Congenital Heart Surgery: A Prospective Observational Study. Indian J Crit Care Med. 2017; 21(12): 847-851. doi: 10.4103/ijccm.IJCCM_459_16.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sales GTM, Foresto RD. Drug-induced nephrotoxicity. Rev. Assoc. Med. Bras. 2020; 66 (1): 82-90 doi: 10.1590/1806-9282.66.S1.82.</mixed-citation><mixed-citation xml:lang="en">Sales GTM, Foresto RD. Drug-induced nephrotoxicity. Rev. Assoc. Med. Bras. 2020; 66 (1): 82-90 doi: 10.1590/1806-9282.66.S1.82.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gómez BCJ, Na G-PH, Álvarez FO et al. Evolución De tubulopatías renales primarias diagnosticadas en edad pediátrica. Nefrologia. 2021; 41: 182-190. doi:10.1016/j.nefroe.2020.07.001.</mixed-citation><mixed-citation xml:lang="en">Gómez BCJ, Na G-PH, Álvarez FO et al. Evolución De tubulopatías renales primarias diagnosticadas en edad pediátrica. Nefrologia. 2021; 41: 182-190. doi:10.1016/j.nefroe.2020.07.001.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Silver SA, Harel Z, McArthur E et al. Causes of Death after a Hospitalization with AKI. JASN. 2018; 29 (3): 1001-1010. doi: 10.1681/ASN.2017080882.</mixed-citation><mixed-citation xml:lang="en">Silver SA, Harel Z, McArthur E et al. Causes of Death after a Hospitalization with AKI. JASN. 2018; 29 (3): 1001-1010. doi: 10.1681/ASN.2017080882.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wiersema, R., Eck, R.J., Haapio, M. et al. Burden of acute kidney injury and 90-day mortality in critically ill patients. BMC Nephrol. 2020; 21: 1-8. doi: 10.1186/s12882-019-1645-y.</mixed-citation><mixed-citation xml:lang="en">Wiersema, R., Eck, R.J., Haapio, M. et al. Burden of acute kidney injury and 90-day mortality in critically ill patients. BMC Nephrol. 2020; 21: 1-8. doi: 10.1186/s12882-019-1645-y.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mihevc M., Petreski T., Maver U. et al. Renal proximal tubular epithelial cells: review of isolation, characterization, and culturing techniques. Mol Biol Rep. 2020; 47: 9865-9882. doi: 10.1007/s11033-020-05977-4.</mixed-citation><mixed-citation xml:lang="en">Mihevc M., Petreski T., Maver U. et al. Renal proximal tubular epithelial cells: review of isolation, characterization, and culturing techniques. Mol Biol Rep. 2020; 47: 9865-9882. doi: 10.1007/s11033-020-05977-4.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Madrazo-Ibarra A, Vaitla P. Histology. Nephron. 2020. [Electronic resource]. URL: https://www.ncbi.nlm.nih.gov/books/NBK554411. (дата обращения: 01.06.2022г).</mixed-citation><mixed-citation xml:lang="en">Madrazo-Ibarra A, Vaitla P. Histology. Nephron. 2020. [Electronic resource]. URL: https://www.ncbi.nlm.nih.gov/books/NBK554411. (дата обращения: 01.06.2022г).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Park HJ, Fan Z, Bai Y et al. Transcriptional Programs Driving Shear Stress-Induced Differentiation of Kidney Proximal Tubule Cells in Culture. Front. Physiol. 2020; 11: 587358. doi: 10.3389/fphys.2020.587358.</mixed-citation><mixed-citation xml:lang="en">Park HJ, Fan Z, Bai Y et al. Transcriptional Programs Driving Shear Stress-Induced Differentiation of Kidney Proximal Tubule Cells in Culture. Front. Physiol. 2020; 11: 587358. doi: 10.3389/fphys.2020.587358.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lin NYC, Homan KA, Robinson SS. et al. Renal reabsorption in 3D vascularized proximal tubule models. PNAS. 2019; 116 (12): 5399-5404. doi: 10.1073/pnas.1815208116.</mixed-citation><mixed-citation xml:lang="en">Lin NYC, Homan KA, Robinson SS. et al. Renal reabsorption in 3D vascularized proximal tubule models. PNAS. 2019; 116 (12): 5399-5404. doi: 10.1073/pnas.1815208116.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Chen L, Clark JZ, Nelson JW et al. Renal-Tubule Epithelial Cell Nomenclature for Single-Cell RNA-Sequencing Studies. J Am Soc Nephrol. 2019; 30(8): 1358-1364. doi: 10.1681/ASN.2019040415.</mixed-citation><mixed-citation xml:lang="en">Chen L, Clark JZ, Nelson JW et al. Renal-Tubule Epithelial Cell Nomenclature for Single-Cell RNA-Sequencing Studies. J Am Soc Nephrol. 2019; 30(8): 1358-1364. doi: 10.1681/ASN.2019040415.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Carney EF. Endocytosis in the proximal tubule. Nat Rev Nephrol. 2019: 15; 2. doi:10.1038/s41581-018-0079-2.</mixed-citation><mixed-citation xml:lang="en">Carney EF. Endocytosis in the proximal tubule. Nat Rev Nephrol. 2019: 15; 2. doi:10.1038/s41581-018-0079-2.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Subramanya AR., Ellison DH. Distal Convoluted Tubule. CJASN. 2014; 9 (12): 2147-2163. doi: 10.2215/CJN.05920613.</mixed-citation><mixed-citation xml:lang="en">Subramanya AR., Ellison DH. Distal Convoluted Tubule. CJASN. 2014; 9 (12): 2147-2163. doi: 10.2215/CJN.05920613.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S, Dong Z. Primary cilia and kidney injury: current research status and future perspectives. Am J Physiol Renal Physiol. 2013; 305(8): F1085-F1098. doi: 10.1152/ajprenal.00399.2013.</mixed-citation><mixed-citation xml:lang="en">Wang S, Dong Z. Primary cilia and kidney injury: current research status and future perspectives. Am J Physiol Renal Physiol. 2013; 305(8): F1085-F1098. doi: 10.1152/ajprenal.00399.2013.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Maggiorani D, Dissard R, Belloy M et al. Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells. PLoS ONE. 2015; 10(7): e0131416. doi:10.1371/journal.pone.0131416.</mixed-citation><mixed-citation xml:lang="en">Maggiorani D, Dissard R, Belloy M et al. Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells. PLoS ONE. 2015; 10(7): e0131416. doi:10.1371/journal.pone.0131416.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Pluznick JL, Caplan MJ. Chemical and Physical Sensors in the Regulation of Renal Function. CJASN. 2015; 10 (9): 1626-1635. doi: /10.2215/CJN.00730114.</mixed-citation><mixed-citation xml:lang="en">Pluznick JL, Caplan MJ. Chemical and Physical Sensors in the Regulation of Renal Function. CJASN. 2015; 10 (9): 1626-1635. doi: /10.2215/CJN.00730114.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Han SJ, Kim J-H, Kim JI et al. Inhibition of microtubule dynamics impedes repair of kidney ischemia/reperfusion injury and increases fibrosis. Sci Rep. 2016; 6: 27775. doi: /10.1038/srep27775.</mixed-citation><mixed-citation xml:lang="en">Han SJ, Kim J-H, Kim JI et al. Inhibition of microtubule dynamics impedes repair of kidney ischemia/reperfusion injury and increases fibrosis. Sci Rep. 2016; 6: 27775. doi: /10.1038/srep27775.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sivakamasundari V, Bolisetty M, Sivajothi S et al. Comprehensive Cell Type Specific Transcriptomics of the Human Kidney. bioRxiv. 2017; 238063. doi: 10.1101/238063.</mixed-citation><mixed-citation xml:lang="en">Sivakamasundari V, Bolisetty M, Sivajothi S et al. Comprehensive Cell Type Specific Transcriptomics of the Human Kidney. bioRxiv. 2017; 238063. doi: 10.1101/238063.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Elias BC, Mathew S, Srichai MB et al. The Integrin β1 Subunit Regulates Paracellular Permeability of Kidney Proximal Tubule Cells. J Biol Chem. 2014; 289(12): 8532-8544. doi: 10.1074/jbc.M113.526509.</mixed-citation><mixed-citation xml:lang="en">Elias BC, Mathew S, Srichai MB et al. The Integrin β1 Subunit Regulates Paracellular Permeability of Kidney Proximal Tubule Cells. J Biol Chem. 2014; 289(12): 8532-8544. doi: 10.1074/jbc.M113.526509.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng G, Zhang J, Zhao H. et al. a3 Integrin of Cell-Cell Contact Mediates Kidney Fibrosis by Integrin-Linked Kinase in Proximal Tubular E-Cadherin Deficient Mice. Am J Pathol. 2016; 186: 1847-1860. doi: 10.1016/j.ajpath.2016.03.015.</mixed-citation><mixed-citation xml:lang="en">Zheng G, Zhang J, Zhao H. et al. a3 Integrin of Cell-Cell Contact Mediates Kidney Fibrosis by Integrin-Linked Kinase in Proximal Tubular E-Cadherin Deficient Mice. Am J Pathol. 2016; 186: 1847-1860. doi: 10.1016/j.ajpath.2016.03.015.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Yu ASL. Claudins and the Kidney. J Am Soc Nephrol. 2015; 26(1): 11-19. doi: 10.1681/ASN.2014030284.</mixed-citation><mixed-citation xml:lang="en">Yu ASL. Claudins and the Kidney. J Am Soc Nephrol. 2015; 26(1): 11-19. doi: 10.1681/ASN.2014030284.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Mitsuhata Y., Abe T., Misaki K. et al. Cyst formation in proximal renal tubules caused by dysfunction of the microtubule minus-end regulator CAMSAP3. Sci Rep. 2021; 11: 5857. doi: 10.1038/s41598-021-85416-x.</mixed-citation><mixed-citation xml:lang="en">Mitsuhata Y., Abe T., Misaki K. et al. Cyst formation in proximal renal tubules caused by dysfunction of the microtubule minus-end regulator CAMSAP3. Sci Rep. 2021; 11: 5857. doi: 10.1038/s41598-021-85416-x.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Tomilin V, Mamenko M, Zaika O, Pochynyuk O. Role of Renal TRP Ion Channels in Physiology and Pathology. Semin Immunopathol. 2016; 38(3): 371-383. doi: 10.1007/s00281-015-0527-z.</mixed-citation><mixed-citation xml:lang="en">Tomilin V, Mamenko M, Zaika O, Pochynyuk O. Role of Renal TRP Ion Channels in Physiology and Pathology. Semin Immunopathol. 2016; 38(3): 371-383. doi: 10.1007/s00281-015-0527-z.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Wang K, Kestenbaum B. Proximal Tubular Secretory Clearance. Clin J Am Soc Nephrol. 2018; 13(8): 1291-1296. doi: 10.2215/CJN.12001017.</mixed-citation><mixed-citation xml:lang="en">Wang K, Kestenbaum B. Proximal Tubular Secretory Clearance. Clin J Am Soc Nephrol. 2018; 13(8): 1291-1296. doi: 10.2215/CJN.12001017.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Евтеев В.А., Прокофьев А.Б., Бунятян Н.Д. и др. МАТЕ-транспортеры: участие в фармакокинетике лекарственных средств и межлекарственных взаимодействиях. Фармация. 2019; 68 (7): 44-47. doi: 10.29296/25419218-2019-07-08.</mixed-citation><mixed-citation xml:lang="en">Evteev V.A., Prokof’ev A.B., Bunjatjan N.D. et al. MATEtransporters: participation in the pharmacokinetics of drugs and drug-drug interactions. Pharmacy. 2019; 68 (7): 44-47.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Simon N., Hertig A. Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis. Front. Med. (Lausanne). 2015; 2: 52. doi: 10.3389/fmed.2015.00052.</mixed-citation><mixed-citation xml:lang="en">doi: 10.29296/25419218-2019-07-08 [in Russian].</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Gai Z, Wang T, Visentin M, et al. Lipid Accumulation and Chronic Kidney Disease. Nutrients. 2019; 11(4): 722. doi: 10.3390/nu11040722.</mixed-citation><mixed-citation xml:lang="en">Simon N., Hertig A. Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis. Front. Med. (Lausanne). 2015; 2: 52. doi: 10.3389/fmed.2015.00052.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Gewin LS. Sugar or Fat? Renal Tubular Metabolism Reviewed in Health and Disease. Nutrients. 2021; 13: 1580. doi: 10.3390/ nu13051580.</mixed-citation><mixed-citation xml:lang="en">Gai Z, Wang T, Visentin M, et al. Lipid Accumulation and Chronic Kidney Disease. Nutrients. 2019; 11(4): 722. doi: 10.3390/nu11040722.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Vasko R. Peroxisomes and Kidney Injury. Antioxid. Redox Signal. 2016; 25: 217-231. doi: 10.1089/ars.2016.6666.</mixed-citation><mixed-citation xml:lang="en">Gewin LS. Sugar or Fat? Renal Tubular Metabolism Reviewed in Health and Disease. Nutrients. 2021; 13: 1580. doi: 10.3390/ nu13051580.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Schreiber A, Rousselle A, Klocke J. et al. Neutrophil Gelatinase– Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting TH17 Immunity. J Am Soc Nephrol. 2020; 31(7): 1569-1584. doi: 10.1681/ASN.2019090879.</mixed-citation><mixed-citation xml:lang="en">Vasko R. Peroxisomes and Kidney Injury. Antioxid. Redox Signal. 2016; 25: 217-231. doi: 10.1089/ars.2016.6666.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Buonafine M, Martinez-Martinez E, Jaisser F. More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clin Sci (Lond). 2018; 132(9): 909-923. doi:10.1042/CS20171592.</mixed-citation><mixed-citation xml:lang="en">Schreiber A, Rousselle A, Klocke J. et al. Neutrophil Gelatinase– Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting TH17 Immunity. J Am Soc Nephrol. 2020; 31(7): 1569-1584. doi: 10.1681/ASN.2019090879.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Solbu MD., Toft I, Lochen ML et al. N-Acetyl-β-d-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population. J Am Soc Nephrol. 2016; 27(2): 533-542. doi: 10.1681/ASN.2014100960.</mixed-citation><mixed-citation xml:lang="en">Buonafine M, Martinez-Martinez E, Jaisser F. More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clin Sci (Lond). 2018; 132(9): 909-923. doi:10.1042/CS20171592.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Kim SR, Lee Y, Lee SG et al. Urinary N-acetyl-β-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes. Medicine (Baltimore). 2016; 95(27): e4114. doi: 10.1097/MD.0000000000004114.</mixed-citation><mixed-citation xml:lang="en">Solbu MD., Toft I, Lochen ML et al. N-Acetyl-β-d-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population. J Am Soc Nephrol. 2016; 27(2): 533-542. doi: 10.1681/ASN.2014100960.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Chachaj A, Matkowski R, Gröbner G et al. Metabolomics of Interstitial Fluid, Plasma and Urine in Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms. Diagnostics (Basel). 2020; 10(11): 936. doi: 10.3390/diagnostics10110936.</mixed-citation><mixed-citation xml:lang="en">Kim SR, Lee Y, Lee SG et al. Urinary N-acetyl-β-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes. Medicine (Baltimore). 2016; 95(27): e4114. doi: 10.1097/MD.0000000000004114.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Gandhi R, Yi J, Ha J et al. Accelerated receptor sheddinginhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis. Am J Physiol Renal Physiol. 2014; 307(2): F205–F221. doi: 10.1152/ajprenal.00638.2013.</mixed-citation><mixed-citation xml:lang="en">Chachaj A, Matkowski R, Gröbner G et al. Metabolomics of Interstitial Fluid, Plasma and Urine in Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms. Diagnostics (Basel). 2020; 10(11): 936. doi: 10.3390/diagnostics10110936.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Tanase DM, Gosav EM, Radu S et al. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity. Int J Mol Sci. 2019; 20(20): 5238. doi: 10.3390/ijms20205238.</mixed-citation><mixed-citation xml:lang="en">Gandhi R, Yi J, Ha J et al. Accelerated receptor sheddinginhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis. Am J Physiol Renal Physiol. 2014; 307(2): F205–F221. doi: 10.1152/ajprenal.00638.2013.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L, Brooks CR, Xiao S et al. KIM-1–mediated phagocytosis reduces acute injury to the kidney. J Clin Invest. 2015; 125(4): 1620-1636.</mixed-citation><mixed-citation xml:lang="en">Tanase DM, Gosav EM, Radu S et al. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity. Int J Mol Sci. 2019; 20(20): 5238. doi: 10.3390/ijms20205238.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Schiano G, Glaudemans B, Olinger E. et al. The Urinary Excretion of Uromodulin is Regulated by the Potassium Channel ROMK. Sci Rep. 2019; 9: 19517. doi: 10.1038/s41598-019-55771-x.</mixed-citation><mixed-citation xml:lang="en">Yang L, Brooks CR, Xiao S et al. KIM-1–mediated phagocytosis reduces acute injury to the kidney. J Clin Invest. 2015; 125(4): 1620-1636.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Micanovic R, LaFavers K, Garimella PS et al. Uromodulin (Tamm–Horsfall protein): guardian of urinary and systemic homeostasis. Nephrol Dial Transplant. 2020; 35(1): 33-43. doi: 10.1093/ndt/gfy394.</mixed-citation><mixed-citation xml:lang="en">Schiano G, Glaudemans B, Olinger E. et al. The Urinary Excretion of Uromodulin is Regulated by the Potassium Channel ROMK. Sci Rep. 2019; 9: 19517. doi: 10.1038/s41598-019-55771-x.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Kipp A, Olinger E. What Does Uromodulin Do? CJASN. 2021; 16(1): 150-153. doi: 10.2215/CJN.06390420.</mixed-citation><mixed-citation xml:lang="en">Micanovic R, LaFavers K, Garimella PS et al. Uromodulin (Tamm–Horsfall protein): guardian of urinary and systemic homeostasis. Nephrol Dial Transplant. 2020; 35(1): 33-43. doi: 10.1093/ndt/gfy394.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Eckardt KU, Alper SL, Antignac C. et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report. Kidney Int. 2015; 88(4): 676-83. doi: 10.1038/ki.2015.28.</mixed-citation><mixed-citation xml:lang="en">Kipp A, Olinger E. What Does Uromodulin Do? CJASN. 2021; 16(1): 150-153. doi: 10.2215/CJN.06390420.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Singh V., Singla SK, Jha, V. et al. Hepatocyte nuclear factor-1β: A regulator of kidney development and cystogenesis. Indian J Nephrol. 2015; 25(2): 70-76. doi: 10.4103/0971-4065.139492.</mixed-citation><mixed-citation xml:lang="en">Eckardt KU, Alper SL, Antignac C. et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report. Kidney Int. 2015; 88(4): 676-83. doi: 10.1038/ki.2015.28.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrè S, Igarashi P. New insights into the role of HNF-1β in kidney (patho)physiology. Pediatr Nephrol. 2019; 34(8): 1325-1335. doi: 10.1007/s00467-018-3990-7.</mixed-citation><mixed-citation xml:lang="en">Singh V., Singla SK, Jha, V. et al. Hepatocyte nuclear factor-1β: A regulator of kidney development and cystogenesis. Indian J Nephrol. 2015; 25(2): 70-76. doi: 10.4103/0971-4065.139492.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Li L, Dong M, Wang XG. The Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator. Chin Med J (Engl). 2016; 129(4): 448-455. doi: 10.4103/0366-6999.176084.</mixed-citation><mixed-citation xml:lang="en">Ferrè S, Igarashi P. New insights into the role of HNF-1β in kidney (patho)physiology. Pediatr Nephrol. 2019; 34(8): 1325-1335. doi: 10.1007/s00467-018-3990-7.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Гасанов М.З., Батюшин М.М., Терентьев В.П. и др. Протеомный спектр мочи пациентов с хроническим гломерулонефритом. Клиническая нефрология. 2012; 5-6: 28-32.</mixed-citation><mixed-citation xml:lang="en">Li L, Dong M, Wang XG. The Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator. Chin Med J (Engl). 2016; 129(4): 448-455. doi: 10.4103/0366-6999.176084.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Гасанов М.З., Батюшин М.М., Терентьев В.П. и др. Особенности протеомного зеркала мочи пациентов с различными гломерулонефропатиями различного генеза. Кубанский научный медицинский вестник. 2012; 4(133): 37-42.</mixed-citation><mixed-citation xml:lang="en">Gasanov M.Z., Batiushin M.M., Terent’ev V.P. et al. Proteomic spectrum of urine of patients with chronic glomerulonephritis. Clinical Nephrology. 2012; 5-6: 28-32 [in Russian].</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Батюшин М.М., Левицкая Е.С., Терентьев В.П. и др. Почечные и коронарные предикторы прогноза у больных ишемической болезнью сердца, перенесших реваскуляризацию миокарда. Российский кардиологический журнал. 2012; 6 (98): 45-50.</mixed-citation><mixed-citation xml:lang="en">Gasanov M.Z., Batiushin M.M., Terent’ev V.P. et al. Features of the proteomic mirror of urine in patients with various glomerulonephropathies of various origins. Kuban Scientific Medical Bulletin. 2012; 4(133): 37-42 [in Russian].</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Zi M, Xu Y. Involvement of cystatin C in immunity and apoptosis. Immunol Lett. 2018; 196: 80-90. doi: 10.1016/j.imlet.2018.01.006.</mixed-citation><mixed-citation xml:lang="en">Batiushin M.M., Levickaja E.S., Terent’ev V.P. et al. Renal and coronary predictors of prognosis in patients with coronary heart disease who underwent myocardial revascularization. Russian Journal of Cardiology. 2012; 6 (98): 45-50 [in Russian].</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Kim SS, Song SH, Kim IJ et al. Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy. Diabetes Care. 2013; 36(3): 656-661. doi: 10.2337/dc12-0849.</mixed-citation><mixed-citation xml:lang="en">Zi M, Xu Y. Involvement of cystatin C in immunity and apoptosis. Immunol Lett. 2018; 196: 80-90. doi: 10.1016/j.imlet.2018.01.006.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические практические рекомендации KDIGO 2012 по диагностике и лечению хронической болезни почек. Нефрология и диализ. 2017; 19(1): 22-206.</mixed-citation><mixed-citation xml:lang="en">Kim SS, Song SH, Kim IJ et al. Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy. Diabetes Care. 2013; 36(3): 656-661. doi: 10.2337/dc12-0849.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Zakiyanov O, Kalousová M, Zima T et al. Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal. Kidney Blood Press Res. 2019; 44: 298-330. doi: 10.1159/000499876.</mixed-citation><mixed-citation xml:lang="en">KDIGO 2012 Clinical Practice Guidelines for Diagnosis and Management of Chronic Kidney Disease. Nephrology and dialysis. 2017; 19(1): 22-206.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Wen X, Zhang J, Wan X. et al. Tissue Inhibitor of Metalloproteinases-2 Mediates Kidney Injury during Sepsis. Nephron. 2020; 144: 644-649. doi: 10.1159/000511165.</mixed-citation><mixed-citation xml:lang="en">Zakiyanov O, Kalousová M, Zima T et al. Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal. Kidney Blood Press Res. 2019; 44: 298-330. doi: 10.1159/000499876.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Jia HM., Huang LF., Zheng Y. et al. Diagnostic value of urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 for acute kidney injury: a metaanalysis. Crit Care. 2017; 21: 77. doi: 10.1186/s13054-017-1660-y.</mixed-citation><mixed-citation xml:lang="en">Wen X, Zhang J, Wan X. et al. Tissue Inhibitor of Metalloproteinases-2 Mediates Kidney Injury during Sepsis. Nephron. 2020; 144: 644-649. doi: 10.1159/000511165.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Jin L, Shen F, Weinfeld M et al. Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk. Front. Oncol. 2020; 10: 727. doi: 10.3389/fonc.2020.00727.</mixed-citation><mixed-citation xml:lang="en">Jia HM., Huang LF., Zheng Y. et al. Diagnostic value of urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 for acute kidney injury: a metaanalysis. Crit Care. 2017; 21: 77. doi: 10.1186/s13054-017-1660-y.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Wang GQ, Bonkovsky HL, Lemos A et al. Recent insights into the biological functions of liver fatty acid binding protein 1. J Lipid Res. 2015; 56(12): 2238-2247. doi: 10.1194/jlr.R056705.</mixed-citation><mixed-citation xml:lang="en">Jin L, Shen F, Weinfeld M et al. Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk. Front. Oncol. 2020; 10: 727. doi: 10.3389/fonc.2020.00727.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Viswanathan V, Sivakumar S, Sekar V et al. Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy. Indian J Nephrol 2015; 25: 269-73. doi: 10.4103/0971-4065.145097.</mixed-citation><mixed-citation xml:lang="en">Wang GQ, Bonkovsky HL, Lemos A et al. Recent insights into the biological functions of liver fatty acid binding protein 1. J Lipid Res. 2015; 56(12): 2238-2247. doi: 10.1194/jlr.R056705.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai IT, Wu CC, Hung WC et al. FABP1 and FABP2 as markers of diabetic nephropathy. Int J Med Sci. 2020; 17(15): 2338-2345. doi: 10.7150/ijms.49078.</mixed-citation><mixed-citation xml:lang="en">Viswanathan V, Sivakumar S, Sekar V et al. Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy. Indian J Nephrol 2015; 25: 269-73. doi: 10.4103/0971-4065.145097.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X, Cobbs A, George J et al. Endocytosis of Albumin Induces Matrix Metalloproteinase-9 by Activating the ERK Signaling Pathway in Renal Tubule Epithelial Cells. Int J Mol Sci. 2017; 18(8): 1758. doi: 10.3390/ijms18081758.</mixed-citation><mixed-citation xml:lang="en">Tsai IT, Wu CC, Hung WC et al. FABP1 and FABP2 as markers of diabetic nephropathy. Int J Med Sci. 2020; 17(15): 2338-2345. doi: 10.7150/ijms.49078.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Bieniaś B, Zajączkowska M, Borzęcka Halina et al. Early Markers of Tubulointerstitial Fibrosis in Children With Idiopathic Nephrotic Syndrome. Medicine. 2015; 94(42): e1746. doi: 10.1097/MD.0000000000001746.</mixed-citation><mixed-citation xml:lang="en">Chen X, Cobbs A, George J et al. Endocytosis of Albumin Induces Matrix Metalloproteinase-9 by Activating the ERK Signaling Pathway in Renal Tubule Epithelial Cells. Int J Mol Sci. 2017; 18(8): 1758. doi: 10.3390/ijms18081758.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Shu KH, Wang CH, Wu CH et al. Urinary π-glutathione S-transferase Predicts Advanced Acute Kidney Injury Following Cardiovascular Surgery. Sci Rep. 2016; 6: 26335. doi: 10.1038/srep26335.</mixed-citation><mixed-citation xml:lang="en">Bieniaś B, Zajączkowska M, Borzęcka Halina et al. Early Markers of Tubulointerstitial Fibrosis in Children With Idiopathic Nephrotic Syndrome. Medicine. 2015; 94(42): e1746. doi: 10.1097/MD.0000000000001746.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Hirooka Y, Nozaki Y. Interleukin-18 in Inflammatory Kidney Disease. Front. Med. 2021; 8: 639103. doi: 10.3389/fmed.2021.639103.</mixed-citation><mixed-citation xml:lang="en">Shu KH, Wang CH, Wu CH et al. Urinary π-glutathione S-transferase Predicts Advanced Acute Kidney Injury Following Cardiovascular Surgery. Sci Rep. 2016; 6: 26335. doi: 10.1038/srep26335.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Y, Zhang ZX, Lian D et al. IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury. Kidney International. 2015; 87: 396-408. doi:10.1038/ki.2014.295.</mixed-citation><mixed-citation xml:lang="en">Hirooka Y, Nozaki Y. Interleukin-18 in Inflammatory Kidney Disease. Front. Med. 2021; 8: 639103. doi: 10.3389/fmed.2021.639103.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Su H, Lei CT, Zhang С et al. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update. Front Immunol. 2017; 8: 405. doi: 10.3389/fimmu.2017.00405.</mixed-citation><mixed-citation xml:lang="en">Yang Y, Zhang ZX, Lian D et al. IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury. Kidney International. 2015; 87: 396-408. doi:10.1038/ki.2014.295.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Norlander AE, Madhur MS. Inflammatory cytokines regulate renal sodium transporters: how, where, and why? Am J Physiol Renal Physiol. 2017; 313(2): F141-F144. doi: 10.1152/ajprenal.00465.2016.</mixed-citation><mixed-citation xml:lang="en">Su H, Lei CT, Zhang С et al. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update. Front Immunol. 2017; 8: 405. doi: 10.3389/fimmu.2017.00405.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Stiegel M.A., Pleil J.D., Sobus J.R. et al. Kidney injury biomarkers and urinary creatinine variability in nominally healthy adults. [Electronic resource]. URL: file:///C:/Users/%D0%95%D0%BA%D0%B0%D1%82%D0%B5%D1%80%D0%B8%D0%BD%D0%B0/Downloads/KIP2%2012242014PRESUB2 %20(1).PDF. (дата обращения: 01.06.2022г).</mixed-citation><mixed-citation xml:lang="en">Norlander AE, Madhur MS. Inflammatory cytokines regulate renal sodium transporters: how, where, and why? Am J Physiol Renal Physiol. 2017; 313(2): F141-F144. doi: 10.1152/ajprenal.00465.2016.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Katou S, Globke B, Morgul M.H et al. Urinary Biomarkers α-GST and π-GST for Evaluation and Monitoring in Living and Deceased Donor Kidney Grafts. J Clin Med. 2019; 8(11): 1899. doi: 10.3390/jcm8111899.</mixed-citation><mixed-citation xml:lang="en">Stiegel M.A., Pleil J.D., Sobus J.R. et al. Kidney injury biomarkers and urinary creatinine variability in nominally healthy adults. [Electronic resource]. URL: file:///C:/Users/%D0%95%D0%BA%D0%B0%D1%82%D0%B5%D1%80%D0%B8%D0%BD%D0%B0/Downloads/KIP2%2012242014PRESUB2 %20(1).PDF. (дата обращения: 01.06.2022г).</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Schinstock CA, Semret MH, Wagner SJ et al. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury. Nephrology Dialysis Transplantation. 2013; 28(5): 1175-1185. doi: 10.1093/ndt/gfs127.</mixed-citation><mixed-citation xml:lang="en">Katou S, Globke B, Morgul M.H et al. Urinary Biomarkers α-GST and π-GST for Evaluation and Monitoring in Living and Deceased Donor Kidney Grafts. J Clin Med. 2019; 8(11): 1899. doi: 10.3390/jcm8111899.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Clerico A, Galli C, Fortunato A et al. Neutrophil gelatinaseassociated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med. 2012; 50(9): 1505-1517. doi 10.1515/cclm-2011-0814.</mixed-citation><mixed-citation xml:lang="en">Schinstock CA, Semret MH, Wagner SJ et al. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury. Nephrology Dialysis Transplantation. 2013; 28(5): 1175-1185. doi: 10.1093/ndt/gfs127.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Hong N, Lee M, Park S et al. Elevated urinary N-acetyl-β-Dglucosaminidase is associated with high glycoalbumin-tohemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease. Sci Rep. 2018; 8: 6710. doi: 10.1038/s41598-018-25023-5.</mixed-citation><mixed-citation xml:lang="en">Clerico A, Galli C, Fortunato A et al. Neutrophil gelatinaseassociated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med. 2012; 50(9): 1505-1517. doi 10.1515/cclm-2011-0814.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Q, Zong R, Li H et al. Distribution of urinary N-acetylbeta- D-glucosaminidase and the establishment of reference intervals in healthy adults. J Clin Lab Anal. 2021; 35(5): e23748. doi: 10.1002/jcla.23748.</mixed-citation><mixed-citation xml:lang="en">Hong N, Lee M, Park S et al. Elevated urinary N-acetyl-β-Dglucosaminidase is associated with high glycoalbumin-tohemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease. Sci Rep. 2018; 8: 6710. doi: 10.1038/s41598-018-25023-5.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Loko F, Robic D, Bondiou MT et al. Concentrations of N-Acetyl- β-D-glucosaminidase and its Intermediate Isoenzymes in Serum of Patients with Renal Transplants. CLINICAL CHEMISTRY. 1991; 37(4):583-584.</mixed-citation><mixed-citation xml:lang="en">Liu Q, Zong R, Li H et al. Distribution of urinary N-acetylbeta- D-glucosaminidase and the establishment of reference intervals in healthy adults. J Clin Lab Anal. 2021; 35(5): e23748. doi: 10.1002/jcla.23748.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Bank J, Ruhaak R, Soonawala D et al. Urinary TIMP-2 Predicts the Presence and Duration of Delayed Graft Function in Donation After Circulatory Death Kidney Transplant Recipients. Transplantation. 2019; 103 (5): 1014-1023. doi: 10.1097/TP.0000000000002472.</mixed-citation><mixed-citation xml:lang="en">Loko F, Robic D, Bondiou MT et al. Concentrations of N-Acetyl- β-D-glucosaminidase and its Intermediate Isoenzymes in Serum of Patients with Renal Transplants. CLINICAL CHEMISTRY. 1991; 37(4):583-584.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Larsen MB, Stephens RW, Brunner N et al. Quantification of Tissue Inhibitor of Metalloproteinases 2 in Plasma from Healthy Donors and Cancer Patients. Scandinavian Journal of Immunology. 2004: 61; 449-460. doi: 10.1111/j.1365-3083.2005.01585.x.</mixed-citation><mixed-citation xml:lang="en">Bank J, Ruhaak R, Soonawala D et al. Urinary TIMP-2 Predicts the Presence and Duration of Delayed Graft Function in Donation After Circulatory Death Kidney Transplant Recipients. Transplantation. 2019; 103 (5): 1014-1023. doi: 10.1097/TP.0000000000002472.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Woziwodzka K, Małyszko J, Koc-Zórawska E et al. Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients. Medicina. 2021; 57: 1348. doi.org/ 10.3390/medicina57121348.</mixed-citation><mixed-citation xml:lang="en">Larsen MB, Stephens RW, Brunner N et al. Quantification of Tissue Inhibitor of Metalloproteinases 2 in Plasma from Healthy Donors and Cancer Patients. Scandinavian Journal of Immunology. 2004: 61; 449-460. doi: 10.1111/j.1365-3083.2005.01585.x.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Kamijo-Ikemori A, Sugaya T, Yasuda T et al. Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients. Diabetes Care. 2011; 34(3): 691-696. doi: 10.2337/dc10-1392.</mixed-citation><mixed-citation xml:lang="en">Woziwodzka K, Małyszko J, Koc-Zórawska E et al. Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients. Medicina. 2021; 57: 1348. doi.org/ 10.3390/medicina57121348.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Di Carlo A. Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma. ONCOLOGY LETTERS. 2014; 7: 621-626. doi: 10.3892/ol.2013.1755.</mixed-citation><mixed-citation xml:lang="en">Kamijo-Ikemori A, Sugaya T, Yasuda T et al. Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients. Diabetes Care. 2011; 34(3): 691-696. doi: 10.2337/dc10-1392.</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Дементьев И.О., Нюшко К.М., Карякин О.Б. и др. Роль биомаркеров острого повреждения почек в прогнозировании функциональных результатов хирургического лечения у больных локализованным раком почки. Исследования и практика в медицине. 2021; 8(3): 97-107. doi: 10.17709/2410- 1893-2021-8-3-9.</mixed-citation><mixed-citation xml:lang="en">Di Carlo A. Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma. ONCOLOGY LETTERS. 2014; 7: 621-626. doi: 10.3892/ol.2013.1755.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Зыков М.В., Кашталап В.В., Быкова И.С. и др. Клиническое и прогностическое значение сывороточного интерлейкина-18 у больных инфарктом миокарда с подъёмом сегмента ST. Российский кардиологический журнал. 2015; 11(127): 70-74. doi: 10.15829/1560-4071-2015-11-70-74.</mixed-citation><mixed-citation xml:lang="en">Dement’ev I.O., Njushko K.M., Karjakin O.B. et al. The role of biomarkers of acute kidney injury in predicting the functional outcomes of surgical treatment in patients with localized kidney cancer. Research and practice in medicine. 2021; 8(3): 97-107. doi: 10.17709/2410-1893-2021-8-3-9 [in Russian].</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Муркамилов И.Т., Айтбаев К.А., Муркамилова Ж.А. и др. Бета-2-микроглобулин как биомаркер при хронической болезни почек. The scientific heritage. 2021; 2 (59): 45-55. doi: 10.24412/9215-0365-2021-59-2-45-55.</mixed-citation><mixed-citation xml:lang="en">Zykov M.V., Kashtalap V.V., Bykova I.S. et al. Clinical and prognostic significance of serum interleukin-18 in patients with ST-elevation myocardial infarction. Russian journal of cardiology. 2015; 11(127): 70-74. doi: 10.15829/1560-4071-2015-11-70-74 [in Russian].</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Главнова О.Б., Ярмолинская М.И., Суслова С.В. и др. Возможности использования цистатина С в диагностике различных заболеваний. Журнал акушерства и женских болезней. 2018; 67(4): 40-47. doi:10.17816/JOWD67440.</mixed-citation><mixed-citation xml:lang="en">Murkamilov I.T., Ajtbaev K.A., Murkamilova Zh.A. et al. Beta-2- microglobulin as a biomarker in chronic kidney disease. The scientific heritage. 2021; 2 (59): 45-55. doi: 10.24412/9215-0365-2021-59-2-45-55 [in Russian].</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Song J, Park DW, Moon S et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis. 2019; 19: 968. doi: 10.1186/s12879-019-4618-7.</mixed-citation><mixed-citation xml:lang="en">Glavnova O.B., Jarmolinskaja M.I., Suslova S.V. et al. Possibilities of using cystatin C in the diagnosis of various diseases. Journal of Obstetrics and Women’s Diseases. 2018; 67(4): 40-47. doi:10.17816/JOWD67440 [in Russian].</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Муркамилов И.Т., Айтбаев К.А., Фомин В.В. и др. Провоспалительные цитокины у больных с хронической болезнью почек: в фокусе интерлейкин-6. Архивъ внутренней медицины. 2019; 9(6): 428-433. doi: 10.20514/2226-6704-2019-9-6-428-433.</mixed-citation><mixed-citation xml:lang="en">Song J, Park DW, Moon S et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis. 2019; 19: 968. doi: 10.1186/s12879-019-4618-7.</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Murkamilov I.T., Ajtbaev K.A., Fomin V.V. et al. Proinflammatory cytokines in patients with chronic kidney disease: focus on interleukin-6. The Russian Archives of Internal Medicine. 2019; 9(6): 428-433. doi: 10.20514/2226-6704-2019-9-6-428-433 [in Russian].</mixed-citation><mixed-citation xml:lang="en">Murkamilov I.T., Ajtbaev K.A., Fomin V.V. et al. Proinflammatory cytokines in patients with chronic kidney disease: focus on interleukin-6. The Russian Archives of Internal Medicine. 2019; 9(6): 428-433. doi: 10.20514/2226-6704-2019-9-6-428-433 [in Russian].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
